All stock lists
Dermapharm Holding SE (Frankfurt:DMP.F)
Germany · Delayed Price · Currency is EUR
Healthcare · Drug Manufacturers - Specialty & Generic
38.25-0.35 (-0.91%)
Market cap
$1.89B
Website
Insider Score
––Not scored
DMP.F Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
DMP.F Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 285.15 M | 305.80 M | 295.53 M | 294.90 M | 272.15 M | — |
| Revenue Growth (YoY) | 4.78 % | — | — | — | — | — |
| Cost of Revenue | 87.52 M | 98.09 M | 91.75 M | 99.07 M | 88.02 M | — |
| Gross Profit | 197.64 M | 207.71 M | 203.78 M | 195.83 M | 184.13 M | — |
| SG&A Expense | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — |
| Operating Expenses | 126.59 M | 137.05 M | 145.59 M | 130.98 M | 139.64 M | — |
| Operating Income | 71.05 M | 70.66 M | 58.19 M | 64.85 M | 44.49 M | — |
| Pretax Income | 29.95 M | 61.51 M | 46.16 M | 55.16 M | 32.53 M | — |
| Tax Provision | 6.79 M | 16.38 M | 10.01 M | 14.05 M | 11.63 M | — |
| Net Income | 23.22 M | 45.20 M | 36.89 M | 41.23 M | 20.89 M | — |
| EPS (Basic) | 0.47 | 0.84 | — | — | 0.39 | 0.62 |
| EPS (Diluted) | 0.47 | 0.84 | — | — | 0.39 | 0.62 |
| Shares Outstanding | 49.41 M | 53.81 M | — | — | 53.57 M | 53.88 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.